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OBJECTIVES This study examined: 1) the impact of myectomy on postoperative mitral regurgitation (MR)
and 2) the association between the severity of MR and the left ventricular outflow tract
(LVOT) gradient.
BACKGROUND For patients with hypertrophic obstructive cardiomyopathy (HOCM) and MR, controversy
exists as to whether myectomy alone is sufficient in eliminating MR. Furthermore, the
relationship between the degree of MR and the LVOT peak gradient has not been well
defined.
METHODS We performed pre- and postoperative transthoracic as well as intraoperative transesophageal
studies in 104 consecutive patients with HOCM undergoing septal myectomy. Left
ventricular outflow tract gradient and the nature of MR were assessed.
RESULTS In the 93 patients without independent mitral valve disease, a relationship was observed
between MR severity and the LVOT gradient. Left ventricular outflow tract gradient
(mean 6 standard deviation) for trivial, mild, moderate and severe MR were: 23.2 6 19.1,
43.8 6 25.4, 70.1 6 21.0 and 104 6 21.0 mm Hg (p , 0.001). Early postoperative, MR was
absent or trivial in 80%, mild in 19% and moderate in 1%. None of these patients required
additional mitral valve surgery. For patients with independent mitral valve disease (n 5 11),
five required mitral valve surgery as well as myectomy. The remainder had significant
reductions in the degree of MR with myectomy alone.
CONCLUSIONS For patients with HOCM and MR not due to independent mitral valve disease, myectomy
significantly reduced the degree of MR, without requirement for additional mitral valve
surgery. In these patients the severity of MR was directly related to the magnitude of the
LVOT gradient. (J Am Coll Cardiol 2000;36:2219–25) © 2000 by the American College of
Cardiology
Hypertrophic cardiomyopathy is a condition caused by
mutations in sarcomeric proteins, which result in abnormal
muscle hypertrophy, particularly in the interventricular sep-
tum (1). Dynamic left ventricular outflow tract (LVOT)
obstruction and the concomitant mitral regurgitation (MR)
both caused by systolic anterior motion (SAM) of the mitral
leaflets characterize the obstructive form of this condition.
Systolic anterior motion is initiated by rapid LV ejection
through an outflow tract narrowed by ventricular septal
hypertrophy and anterior displacement of the mitral valve
apparatus (2,3). This results in production of a Venturi, or
drag forces (4,5), which draw both the mitral leaflets and
chordae towards the interventricular septum causing leaflet-
septal contact and obstruction at this site (Fig. 1) (3,6–9).
We have previously demonstrated that MR is related to
SAM of the anterior mitral leaflet and failure of the
posterior leaflet to move as much forward as the anterior
leaflet (9). This results in an interleaflet gap through which
the MR is posteriorly directed into the left atrium (Fig. 2A)
(9). In most patients with hypertrophic obstructive cardio-
myopathy (HOCM), the MR that is dependent on SAM
peaks in mid and late systole (8–11).
Significant MR independent of SAM may occur in up to
10% to 20% of patients with HOCM (3,12). Abnormalities
causing independent MR include mitral valve prolapse
(MVP) (13), chordal rupture (14), traumatic fibrosis of the
anterior mitral valve leaflet from repeated septal contact
(3,12,15), marked mitral annular calcification (MAC) and
anomalous attachment of a papillary muscle to the anterior
mitral valve leaflet (3,12,16). Independent MR is usually
directed anteriorly (Fig. 2B) or centrally into the left atrium
and is usually holosystolic (Fig. 2C) (9). Some investigators
have suggested that, in addition to myectomy, mitral valve
replacement is also required in many patients to eliminate
MR (17).
Previous angiographic (11) indicator dye dilution (12)
and echocardiographic (echo) studies (10) have demon-
strated that MR is worse with greater degrees of LVOT
obstruction. However, a quantitative relationship between
MR severity and LVOT gradient has not been established.
The purpose of this echo study was to examine the rela-
tionship between the nature and severity of MR and
subsequent requirement for mitral valve surgery for patients
undergoing surgical myectomy.
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METHODS
The study group consisted of 104 consecutive patients with
HOCM undergoing septal myectomy at the Toronto Gen-
eral Hospital. The diagnosis of HOCM was made when
there was echo evidence of asymmetric hypertrophy of the
interventricular septum (septal/free wall thickness .1.5/1.0)
and a dynamic LVOT gradient. The study population
included 68 men and 36 women with a mean (6 standard
deviation) age of 45 6 11 years (range 23 to 74 years). The
total population of 104 patients was then classified into two
groups. Group 1 consisted of 93 patients (89% of the total
group), with no significant independent mitral valve abnor-
mality detected by preoperative echo. Group 2 patients (n 5
11, 11% of the total group) had significant independent
mitral valve disease. Patients were followed in the hypertro-
phic cardiomyopathy clinic and were on negative inotropic
medical therapy (beta-adrenergic blocking agents, disopyr-
amide or a combination) in an attempt to reduce the LVOT
gradient. The indications for surgery were persistent dis-
abling clinical symptoms despite optimal medical therapy
and evidence of a significant LVOT gradient, either at rest
or with provocation.
All group 1 patients (n 5 93) underwent myectomy
without concomitant requirement for mitral valve surgery.
Concomitant operative procedures in this group included:
coronary artery bypass surgery (n 5 12), releasing of a
myocardial bridge (n 5 2), aortic valve replacement (n 5 2),
aortic valve repair (n 5 1), VSD repair (n 5 1), patent
ductus arteriosus closure (n 5 1), aortic arch replacement
(n 5 1) and right ventricular outflow tract resection (n 5 2).
In the group 2 patients with independent mitral valve
disease, 5 of 11 patients, all with at least moderate MVP,
underwent mitral valve surgery in addition to myectomy,
with mitral valve repair in four. The other six patients
underwent myectomy alone. This study was approved by a
human subject ethics committee of the Toronto General
Hospital.
Echocardiographic methods. All patients underwent
comprehensive preoperative transthoracic echo assessment
at a mean (6 standard deviation) of 3 (6 2) days before
operation to assess the degree and extent of hypertrophy, the
severity and direction of MR and the LVOT gradient. The
peak LVOT gradient was determined by continuous wave
Doppler flow signals across the LVOT. The average of five
Doppler signals was taken across the LVOT to ensure
accuracy in the determination of LVOT gradient. The
pressure gradient across the LVOT was calculated using the
modified Bernoulli equation, (peak gradient 5 4v2) (18).
Intraoperative transesophageal studies (TEE) were per-
formed using commercially available echo imaging systems
(Hewlett-Packard Sonos 1000, 1500 or 2500 Ultrasound
Imaging System; Andover, Massachusetts) with a 5 MHz.
multiplane, phased array transducer in 95% of cases and a
biplane probe in the remaining 5% of cases. Studies were
performed after induction of general anesthesia, before
sternotomy and after coming off cardiopulmonary bypass.
Preoperatively, an assessment was made about the extent
and site of myectomy required, the presence of abnormali-
ties of the mitral apparatus and the degree of MR. Imme-
diate postoperative studies evaluated residual outflow tract
gradients, MR and surgical complications. All pressure
gradients and measurements of MR jet areas were made
using the transthoracic images. All patients also underwent
predischarge transthoracic echo studies (mean 5 days post-
op). Studies were recorded on 0.5 inch videotape for
subsequent retrieval and independent analysis by two
blinded observers (E.Y. and A.O.).
The MR jet area was measured from the maximal MR
jet, either in the four-chamber plane or the frontal long-axis
plane. Pulmonary venous flows were obtained from the right
and left pulmonary veins, and peak systolic and diastolic
flow velocities were calculated. The severity of MR was
analyzed off-line using color jet area mapping in combina-
tion with the pulmonary venous flow characteristics ob-
tained. Mitral regurgitation was classified as follows: trivi-
al—color jet area was ,2.0 cm2, mild—color jet area 2.0 to
3.9 cm2, moderate—color jet area 4.0 to 8.0 cm2 with
normal pulmonary venous flow and severe—color jet area
.8.0 cm2 with pulmonary venous systolic blunting of 50%
or more or flow reversal (19,20). The two observers remea-
sured MR jet area and LVOT gradient from 11 preoperative
studies to assess observer variability.
Statistical methods. Statistical analysis was performed uti-
lizing SPSS for Windows (Version 8.0). Group 1 and 2
patients were analyzed separately. Continuous variables are
expressed as mean 6 standard deviation. The peak LVOT
gradient was compared with MR jet area by linear regres-
sion analyses. The LVOT peak gradient across the four MR
groups (trivial to severe) were compared by one way analysis
of variance and by paired t tests (corrected for multiple
comparisons; p 5 0.05/6 5 0.008). The relationship be-
tween MR jet area (dependent variable), time of echo study
(pre- versus postmyectomy) and preoperative MR severity
was analyzed using two-way repeated-measures analysis of
variance. Categorical variables were compared using Fischer
exact test. The significance value for analysis of variance and
Fisher exact test was set at 0.05 (two-sided). In the 11
studies that were measured twice by the observers, the
variability was expressed as the standard deviation of the
difference between the original and repeat measurement as
Abbreviations and Acronyms
echo 5 echocardiography
HOCM 5 hypertrophic obstructive cardiomyopathy
LVOT 5 left ventricular outflow tract
MAC 5 mitral annulus calcification
MR 5 mitral regurgitation
MVP 5 mitral valve prolapse
SAM 5 systolic anterior motion
TEE 5 transesophageal echocardiography
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well as a percentage of the average of the two measurements
(percentage difference).
RESULTS
Preoperative correlation between the degree of MR and
the LVOT pressure gradient. Patients without indepen-
dent mitral valve disease (group 1) were classified as having
trivial (n 5 25), mild (n 5 19), moderate (n 5 34) or severe
MR (n 5 15). There was a corresponding increase in the
mean pressure with increasing severity of MR (Table 1).
When the peak LVOT gradient of individual patients was
plotted against the MR jet area (Fig. 3), the regression line
for the group 1 patients was MR jet area 5 0.07 gradient 1
0.43 (r 5 0.85, SEE 5 1.65). When patients with a resting
gradient of 30 mm Hg or less were excluded, the regression
line was MR jet area 5 0.07 gradient 1 0.92 (r 5 0.70,
SEE 5 1.85). For patients with independent MR (group 2),
there was only a weak relationship between the degree of
MR and the LVOT gradient, as shown in Table 2. The
regression equation for the group 2 patients was y 5 0.25
gradient post—0.92 (r 5 0.60, SEE 5 0.70). The observer
variability for the determination of MR jet area and LVOT
gradient was 0.2 cm2 and 2 mm Hg (percentage difference
of 5 and 3%, respectively).
MR jet direction. In group 1 patients MR jet was poste-
riorly directed in 90/93 (97%) and centrally directed in 3/93
(3%). In these three patients, two were greater than 60 years
of age and had mild MAC. This is in contrast with the
group 2 patients where a different distribution in jet direc-
tion was noted. Although all of these patients had a small
posteriorly directed MR jet as a result of SAM, the
predominant MR jet direction was either anteriorly or
centrally directed. In one patient with bileaflet MVP, the
MR was centrally directed. In six patients with posterior
leaflet MVP, the jet was anteriorly directed. In the three
patients with severe MAC and the patient with mitral
stenosis (Fig. 2C), the MR was central. There was a
significant difference in the proportion of patients with
predominantly posterior directed MR between group 1 and
group 2 (97 vs. 0%; [p , 0.001]).
Results of myectomy. For each category of preoperative
MR in group 1 patients, the pre- and postoperative MR jet
Figure 1. Intraoperative transesophageal echocardiography images demon-
strating systolic anterior motion of the anterior mitral valve leaflet (upper
right panel) and an interleaflet gap (lower left panel) through which a jet
of mitral regurgitation (lower right panel) is centrally directed into the left
atrium. The central jet is due to the combination of LVOT obstruction and
posterior mitral valve leaflet prolapse. Ao 5 aorta; LA 5 left atrium; LV 5
left ventricle.
Figure 2. Transesophageal echocardiography images in three patients with hypertrophic obstructive cardiomyopathy showing: (A) Posteriorly directed
mitral regurgitation jet (arrow) in a patient without independent abnormality of the mitral valve. (B) Anteriorly directed mitral regurgitation jet (arrow)
in a patient with posterior mitral valve leaflet prolapse. (C) Centrally directed jet of mitral regurgitation (arrow) in a patient with mitral stenosis. Ao 5
aorta; LV 5 left ventricle; MR5 mitral regurgitation.
Table 1. Relationship Between the Degree of Mitral
Regurgitation and LVOT Peak Gradient
MR
Classification
MR Jet
Area (cm2)
Mean LVOT
Peak Gradient
(mm Hg)
Trivial 1.05 6 0.18* 23.2 6 19.1*
Mild 2.98 6 0.42* 43.8 6 25.4*
Moderate 6.33 6 0.30* 70.1 6 21.0*
Severe 9.35 6 0.96* 104.0 6 21.0*
Values are expressed as mean 6 SD.
*p , 0.001 by analysis of variance and pairwise testing.
LVOT 5 left ventricular outflow tract; MR 5 mitral regurgitation.
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areas were compared (Fig. 4). Postoperatively all patients
experienced a significant reduction in the degree of MR.
Mitral regurgitation was trivial or absent in 80% (n 5 74),
mild in 19% (n 5 18) and moderate in 1% (n 5 1). In this
latter patient the residual LVOT gradient was 39 mm Hg
(incomplete relief of SAM, LVOT gradient and MR),
whereas in all other group 1 patients (92/93) the residual
LVOT gradient was ,20 mm Hg. Two-way repeated-
measures analysis of variance showed a significant effect of
time (pre- vs. postmyectomy) and preoperative MR severity
on MR jet area (p , 0.001 for both comparisons); the
interaction between time and preoperative MR severity was
also significant (p , 0.001).
For group 2 patients with concomitant mitral valve
disease, five patients required mitral valve surgery in addi-
tion to myectomy. Four patients underwent mitral valve
repair for posterior leaflet MVP. In one patient the intra-
operative TEE demonstrated the presence of ruptured
chords, and severe degrees of MVP was noted in the other
three patients. One patient was noted to have severe MR on
the immediate postpump TEE. Reexploration revealed
inadvertent transection of the mitral chordae, which re-
quired mechanical mitral valve replacement. In follow-up
these five patients who underwent mitral valve surgery had
trace or no MR postoperatively. In the remaining six
patients (two MVP, one rheumatic mitral valve, three severe
MAC) myectomy alone was performed. In all of these cases
there was a significant reduction in the degree of MR from
the preoperative state without the requirement for concom-
itant mitral valve surgery (Table 2). It appears that even in
the presence of concomitant mitral valve disease in some
cases myectomy alone is sufficient to significantly reduce the
degree of MR.
DISCUSSION
Relationship between outflow tract gradient and MR. In
patients with HOCM but without intrinsic mitral valve
disease, we have demonstrated that myectomy alone is
sufficient in eliminating MR. In this same group there is
also a quantitative relationship between LVOT gradient and
the degree of MR. This relationship is preserved even when
patients with resting gradients ,30 mm Hg are excluded.
We demonstrated that in some patients the degree of
dependent MR can be under or overestimated based on the
LVOT gradient. While the size of the interleaflet gap
causing MR varies directly with the degree of SAM and the
Figure 3. The relationship between the LVOT gradient and the mitral
regurgitation jet area. LVOT 5 left ventricular outflow tract.
Table 2. Characteristics of Patients With Independent Mitral Regurgitation (Group 2)
Patient Gender Age MV Disease
Concomitant
MV Surgery
MRJA Pre-op
(cm2)
LVOT PG Pre-op
(mm Hg)
MRJA Post-op
(cm2)
1 M 43 MVP—posterior leaflet MV repair 7.9 71 1.0
2 M 74 MVP—posterior leaflet MV repair 9.4 75 1.0
3 F 38 MVP—posterior leaflet MV repair 6.5 58 1.2
4 F 33 MVP—posterior leaflet MV replacement 9.2 82 1.0
5 F 40 MVP—posterior leaflet MV repair 7.8 65 0.0
6 M 33 MVP—posterior leaflet none 8.5 70 4.1
7 F 50 MVP—bileaflet none 7.4 60 2.0
8 F 57 Rheumatic mitral stenosis none 6.9 90 0.8
9 F 59 MAC none 3.0 36 1.0
10 F 62 MAC none 6.1 65 1.0
11 M 61 MAC none 6.8 74 2.2
LVOT 5 left ventricular outflow tract; MAC 5 mitral annular calcification; MRJA 5 mitral regurgitation jet area; MV 5 mitral valve; MVP 5 mitral valve prolapse; PG 5
peak gradient.
Figure 4. The mitral regurgitation jet area pre- and postmyectomy. MR 5
mitral regurgitation.
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obstructive gradient, variations in mitral leaflet length and
mobility are also important in determining the degree of
MR (21). A previous intraoperative TEE study has shown
that both the anterior and posterior mitral leaflets of
patients with HOCM are longer than in normal controls
(9,21). Residual leaflet tissue after the point of mitral leaflet
coaptation is present (9,21). This helps to initiate leaflet
SAM but also may reduce the degree of late systolic
malcoaptation of the leaflets. An intraoperative TEE study
of a group of 23 patients demonstrated that variations in
posterior leaflet length and mobility were associated with
interindividual differences in the relationship between MR
and the LVOT gradient (22). This study suggested that the
degree of MR correlated inversely with the length over
which the leaflets coapted. Thus, underestimation of the
degree of MR can be due to limitations in quantitation by
color flow mapping, and jet eccentricity, as well as differ-
ences in leaflet angulation.
MR and intrinsic mitral valve disease. Previous discrep-
ancies in the relationship between the severity of MR and
the LVOT pressure gradient are also due to the lack of
recognition of independent disease of the mitral leaflets,
annulus and papillary muscles. While these abnormalities
can be recognized by transthoracic studies, they are opti-
mally assessed by TEE. Other mitral valve pathology that
has been reported in patients with HOCM include: MVP
(13,23), flail posterior leaflet from chordal rupture (14,24),
abnormal insertion of a papillary muscle head directly into
the anterior mitral leaflet (3,12,16), fibrosis of the anterior
mitral leaflet due to repeated leaflet-septal contact (3),
leaflet destruction due to endocarditis (25), excessive elon-
gation of the posterior leaflet (26), rheumatic disease as
demonstrated in one of our patients and MAC, especially in
patients over the age of 50. In all three patients with severe
MAC, myectomy alone was adequate to leave only a trace or
mild residual MR and avoid difficult mitral annular debride-
ment and valve replacement.
Direction of the MR jet and underlying mitral valve
disease. The direction of the MR jet was useful in identi-
fying patients with independent mitral disease and the need
for mitral valve surgery. For patients with HOCM, mitral
leaflet-septal contact caused a posteriorly directed jet of MR
in 97% of our patients in group 1. For patients with
associated independent mitral valve disease, significant dif-
ferences in the direction of the MR jet was noted. When
compared with the group 1 patients, none of these patients
had isolated posteriorly directed MR jets. This difference in
the predominant direction of the MR jet reflects differences
in the mechanism responsible for MR between group 1 and
group 2 patients.
Intraoperative TEE and surgical decision making. My-
otomy or myectomy is an established surgical procedure for
symptomatic HOCM unresponsive to medical treatment
(27–38). Surgical relief of LVOT obstruction should simul-
taneously alleviate the MR if SAM is the predominant
mechanism for MR. Intraoperative TEE has been shown to
be essential in intraoperative decision making for patients
undergoing surgical myectomy (9,39). Successful surgery
requires adequate resection of subaortic muscle, recognition
of the need for concomitant procedures and postoperative
confirmation of the adequacy of surgery.
This study demonstrates that successful surgical myec-
tomy can significantly reduce or abolish the degree of MR
without the requirement for concomitant mitral valve sur-
gery in all patients without independent mitral valve disease.
This usually requires an extensive muscle resection, which
can be guided by the TEE. The myectomy should be
extended 1 cm below the site of mitral leaflet-septal contact
to provide complete relief of the obstruction. The need for
revision of the myectomy site was not required in our
patients but has been required in up to 14% of patients in
other studies (39). Residual MR after successful myectomy
should be no worse than mild and can be explained by
residual traumatic leaflet thickening or minor degrees of
mitral annular calcification.
Concomitant operative strategies at the time for myec-
tomy have attempted to reduce the influence of the in-
creased mitral valve leaflet area and malpositioning of the
subvalvular apparatus, thus reducing the risk of persistent
SAM and outflow tract obstruction. Although mitral valve
replacement was performed as the primary surgical inter-
vention in a significant percentage of patients in several
studies (33,37,38,40,41), this strategy exposes patients to
the inherent risks of prosthetic valves and anticoagulation
therapy. In our institution we have rarely replaced a mitral
valve in these patients and have done so only when there is
a significant independent abnormality of the mitral valve
causing severe MR.
Presently, septal myectomy is still the most frequent
operation for this disease (27,42,43). Others have recom-
mended a combination of myectomy with either plication or
extension of the mitral leaflet (36,44). Newer surgical
approaches including extended and deep ventricular septec-
tomy combined with reconstruction of the subvalvular
mitral apparatus have also been suggested (34). However,
this study demonstrates that none of these complex proce-
dures are required for successful results.
Study limitations. This study is a retrospective analysis of
a selected group of patients at a tertiary referral center. Due
to the established surgical expertise of a single surgeon, the
operative findings in this study may not be generalizable to
other centers due to the variability in surgical technique.
Another limitation of this study includes the assessment of
MR by the use of MR jet area. Although this is a generally
accepted method, the area of the MR jet may have been
underestimated due to the eccentricity of these jets as the
majority are directed posteriorly (45). However, we feel that,
despite the possible underestimation, the results are inter-
nally valid, as underestimation of the MR jet would apply to
the entire patient cohort and would not bias our results
among the four groups of patients. The inaccurate assess-
ment of these eccentric MR jets may also account for some
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of the outliers that occur when the MR jet area is plotted
against the LVOT pressure gradient.
Conclusions. For patients with HOCM and MR as a
result of SAM, myectomy will reduce the severity of MR
without the need for additional mitral valve surgery. For
patients without independent mitral valve disease, there is a
relationship between the LVOT gradient and MR jet area.
The presence of posteriorly directed MR can predict with
certainty those whose MR will significantly improve with
myectomy. For patients with HOCM and concomitant
mitral valve disease, mitral valve surgery may be required.
However, in some of these patients myectomy alone may be
sufficient to abolish or alleviate MR. Echocardiography
plays an important role in the prediction of which patients
will require a mitral valve procedure in addition to myec-
tomy as well as in perioperative decision making.
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